[ Price : $8.95]
The White House credits FDA actions in helping to reduce cancer drug shortages.[ Price : $8.95]
Abbott recalls its Proclaim and Infinity implantable pulse generators due to complaints from patients who are unable to exit MRI m...[ Price : $8.95]
FDA accepts for priority review a Madrigal Pharmaceuticals NDA for resmetirom and its use in treating adult patients with nonalcoh...[ Price : $8.95]
Federal Register notice: FDA determines that Gemini Laboratories Oxandrin (oxandrolone) tablets, 2.5 mg and 10 mg, were withdrawn ...[ Price : $8.95]
Pharmaceutical Research and Manufacturers of America says FDA should take a more flexible approach to determining good cause for f...[ Price : $8.95]
Bipartisan lawmakers introduce legislation in the Senate and House to close a patent-listing loophole that drug manufacturers use ...[ Price : $8.95]
An FDA advisory committee votes 9 to 3 that the benefits of Alnylam Pharmaceuticals patisiran (Onpattro) outweigh its risks for tr...[ Price : $8.95]
FDA medical reviewers question the efficacy of Alnylam Pharmaceuticals patisiran for an expanded population sought in an sNDA.